Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Andrea Falconeri"'
Autor:
Camillo Porta, Vittorio Ferrari, Paolo A. Zucali, Giuseppe Fornarini, Antonio Bernardo, Andrea Falconeri, Sandra Santarossa, Carmine Tinelli, Mimma Rizzo, Giovanni Pappagallo, Alessandra Bearz
Publikováno v:
Journal of Onco-Nephrology. 6:107-114
Background: Sunitinib is still a recommended treatment option for metastatic renal cell carcinoma (RCC) patients; lack of cross-resistance to sequential antiangiogenic drugs has been postulated. Objective: The possibility of a successful rechallenge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d62f6d4616d65db03d8cc0effe9f7c4
https://doi.org/10.1177/23993693221093653
https://doi.org/10.1177/23993693221093653
Autor:
Ambra Raimondi, Gianluigi Poma, Domenico Zanaboni, Carolina Dellafiore, Elisabetta Above, Andrea Agostinelli, Catherine Klersy, Virginia Valeria Ferretti, Anna Maria Grugnetti, Andrea Falconeri, Vittoria Infantino, Lorena Sega, Valeria Meroni, Antonio Piralla, Fausto Baldanti, Carlo Filice
Publikováno v:
American Journal of Medical and Clinical Sciences. 6
Background/Objectives: During the SARS-CoV-2 pandemic currently ongoing worldwide, several challenges were encountered in managing patients in out-of-hospital residences. The aim of this study is to establish a risk score indicating the probability o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23436057daac52b9208aaf4a3f215e5c
https://doi.org/10.33425/2832-4226/21005
https://doi.org/10.33425/2832-4226/21005
Autor:
Andrea Falconeri, Giovanni L. Pappagallo, Paolo Andrea Zucali, Vittorio Ferrari, Alessandra Ferrari, Antonio Bernardo, Giuseppe Fornarini, Camillo Porta, Sandra Santarossa, Alessandra Bearz
Publikováno v:
Journal of Clinical Oncology. 35:e16081-e16081
e16081 Background: Sunitinib is a 1st-line standard of care in mRCC. Lack of cross-resistance to sequential VEGF-targeting drugs and the possibility of a successful rechallenge with Sunitinib have been postulated. Whether mRCC patients (pts) could be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcabffba05c6c7920ff28f21a1e59c97
https://doi.org/10.1200/jco.2017.35.15_suppl.e16081
https://doi.org/10.1200/jco.2017.35.15_suppl.e16081